Valeant Pharma strikes US$250-million friendly deal to buy Solta Medical - InfoNews

Current Conditions

Mostly Cloudy
5.8°C

Valeant Pharma strikes US$250-million friendly deal to buy Solta Medical

December 16, 2013 - 5:41 AM

LAVAL, Que. - Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a friendly deal to acquire Solta Medical, Inc. a California-based company that makes medical devices used in cosmetic surgery procedures.

The Montreal-area company's offer of US$2.92 per share for all of Solta's stock is valued at US$250 million, a 40 per cent premium to Friday's closing price on Nasdaq.

Solta's board of directors supports offer, which requires that Valeant gets at least a majority of Solta's shares.

News from © The Canadian Press, 2013
The Canadian Press

  • Popular penticton News
  • Comments
View Site in: Desktop | Mobile